Cite

    Saksø, M., Jensen, K., Andersen, M., Hansen, C. R., Eriksen, J. G., & Overgaard, J. (2020). dAHANCA 28: A phase I/II feasibility study of hyperfractionated, accelerated radiotherapy with concomitant cisplatin and nimorazole (HART-CN) for patients with locally advanced, HPV/p16-negative squamous cell carcinoma of the oropharynx, hypopharynx, larynx and oral cavity. Radiotherapy and oncology, 148, 65–72. http://access.bl.uk/ark:/81055/vdc_100105277288.0x00004b